Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 612-616

  Yang, Hui ^a   Li, Jing ^a   Tang, Ruihua ^a   Liu, Yaxiong ^a   Shao, Yan ^a   Huang, Qingsheng ^a   Shi, Junling ^a  

^a NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

Breast Neoplasms; Genetic; Lung Neoplasms; Polymorphism; Telomerase

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; ETHNICITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; META ANALYSIS; SENSITIVITY ANALYSIS; ENZYMOLOGY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; NEOPLASM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TELOMERASE;

EID: 84923629225     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893087     Document Type: Article

References (26)

1. Bredberg A: Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer, 2011; 117(3): 440–45
2. Kim N W, Piatyszek M A, Prowse K R et al: Specific association of human telomerase activity with immortal cells and cancer. Science, 1994; 266(5193): 2011–15
3. Nakamura TM, Morin GB, Chapman KB et al: Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997; 277(5328): 955–59
4. Strazisar M, Mlakar V, Glavac D: The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC). Cell Mol Biol Lett, 2009;14: 442–56
5. Zeng B, Hu J, Yuan R et al: Increased expression of importin13 in endometriosis and endometrial carcinoma. Med Sci Monit, 2012; 18(6): CR361–67
6. Zhu CQ, Cutz JC, Liu N et al: Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer, 2006; 94: 1452–59
7. Xie M, Chen Q, He S et al: Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo. Oncol Rep, 2011; 26: 1019–27
8. Zhang Y, Chen L, Yang S, Fang D: E2F1: a potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc. Med Sci Monit, 2012; 18(1): RA12–15
9. Burke LS, Hyland PL, Pfeiffer RM et al: Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One, 2013; 8(8): e71121
10. Pellatt AJ, Wolff RK, Torres-Mejia G et al: Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study. Genes Chromosomes Cancer, 2013; 52(7): 595–609
11. Wang HM, Zhang XY, Jin B: TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects. Genet Test Mol Biomarkers, 2013; 17(12): 937–41
12. Qi HY, Zou P, Zhao L et al: TERT rs2736098 polymorphism and cancer risk: results of a meta-analysis. Asian Pac J Cancer Prev, 2012; 13(7): 3483–88
13. Savage SA, Chanock SJ, Lissowska J et al: Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer, 2007; 97(6): 832–36
14. Hosgood HD III, Menashe I, Shen M et al: Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis, 2008; 29(10): 1938–43
15. Guey LT, García-Closas M, Murta-Nascimento C et al., EPICURO/Spanish Bladder Cancer Study investigators: Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol, 2010; 57(2): 283–92
16. Rafnar T, Sulem P, Stacey SN et al: Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet, 2009; 41(2): 221–27
17. Choi JE, Kang HG, Jang JS et al: Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 2009; 18(10): 2773–81
18. Shen J, Gammon MD, Wu HC et al: Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2010; 19(1): 219–28
19. Pande M, Spitz MR, Wu X et al: Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis, 2011; 32(10): 1493–99
20. Liu Z, Ma H, Wei S et al: Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev, 2011; 20(12): 2642–45
21. Hofer P, Baierl A, Bernhart K et al: Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk. Mol arcinog, 2012; 51(Suppl.1): E176–82
22. Walsh K M, Gorlov I P, Hansen H M et al: Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev, 2013; 22(2): 251–60
23. Sheng X, Tong N, Tao G et al: TERT polymorphisms modify the risk of acute lymphoblastic leukemia in Chinese children. Carcinogenesis, 2013; 34(1): 228–35
24. Iizuka T, Sawabe M, Takubo K, et al: hTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer. Springerplus, 2013; 2(1): 249
25. Zhang W, Chen Y, Yang X et al: Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease. PLoS One, 2012; 7(10): e47029
26. Seow WJ, Cawthon RM, Purdue MP et al: Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res, 2014; 74(15): 4090–98